Robin G Leikin

  • 437 Citations
1983 …2018

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Dr. Leikin joined the administration of the Robert H. Lurie Comprehensive Cancer Center in 1989 and has served as the Scientific Program Director of the Lurie Cancer Center for more than twelve years. She has 16 peer reviewed publications from her laboratory research years. Dr. Leikin has considerable expertise in integrating multi-investigator and training programs. She was instrumental in the Cancer Center obtaining a Breast Program Planning Grant (CA65764), a Prostate Program Planning Grant (CA69851), the SPORE in Breast Cancer (CA89018) and the SPORE in Prostate Cancer (CA90386). Dr. Leikin has also served continuously as Administrative Director for the NCI-funded Training Program in Signal Transduction and Cancer (T32 CA070085), the Clinical Oncology Research Training Program (T32 CA079447), the Training Program in Oncogenesis and Developmental Biology (T32 CA080621) and the SPORE in Prostate Cancer (P50 CA090386). Since 1999 Dr. Leikin has served as Director for the CURE supplement to the Lurie Cancer Center’s Core grant (P30 CA60553)that enables underserved minority undergraduate students to conduct biomedical research during the summer months. Over 100 students have participated in the CURE Program.

Education/Academic qualification

PhD, Northwestern University

… → 1983

Research interests

  • Graduate Medical Education
  • Prostate Cancer

Fingerprint Dive into the research topics where Robin G Leikin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Grants

  • Research Output

    • 437 Citations
    • 15 Article

    A mechanism of resistance to glucocorticoids in multiple myeloma: Transient expression of a truncated glucocorticoid receptor mRNA

    Moalli, P. A., Pillay, S., Weiner, D., Leikin, R. G. & Rosen, S. T., Dec 1 1992, In : Blood. 79, 1, p. 213-222 10 p.

    Research output: Contribution to journalArticle

  • 95 Scopus citations

    Immunotherapy in acute arsenic poisoning

    Leikin, J. B., Goldman-Leikin, R. E., Evans, M. A., Wiener, S. & Hryhorczuk, D. O., Jan 1 1991, In : Clinical Toxicology. 29, 1, p. 59-70 12 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Characterization of a novel myeloma cell line, MM.1

    Goldman-Leikin, R. E., Salwen, H. R., Herst, C. V., Variakojis, D., Lu Bian, M., Le Beau, M. M., Selvanayagan, P., Marder, R., Anderson, R., Weitzman, S. & Rosen, S. T., Jan 1 1989, In : The Journal of Laboratory and Clinical Medicine. 113, 3, p. 325-334 10 p.

    Research output: Contribution to journalArticle

  • 5 Scopus citations

    Characterization of a novel myeloma cell line, MM.1

    Goldman-Leikin, R. E., Salwen, H. R., Herst, C. V., Variakojis, D., Bian, M. L., Le Beau, M. M., Selvanayagan, P., Marder, R., Anderson, R., Weitzman, S. & Rosen, S. T., Jan 1 1989, In : Journal of Laboratory and Clinical Medicine. 113, 3, p. 335-345 11 p.

    Research output: Contribution to journalArticle

  • 43 Scopus citations

    Progress in the treatment of cutaneous T cell lymphomas with radiolabeled monoclonal antibodies

    Rosen, S. T., Zimmer, A. M., Goldman-Leikin, R., Kazikiewicz, J. M., Dykewicz, M. S., Silverstein, E. A., Spies, S. M. & Kaplan, E. H., 1989, In : International Journal of Radiation Applications and Instrumentation.. 16, 6, p. 667-668 2 p.

    Research output: Contribution to journalArticle

    15 Scopus citations